You have 9 free searches left this month | for more free features.

Ruxolitinib

Showing 26 - 50 of 345

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

A PMS of JakaviĀ® in Steroid-Refractory Graft-versus-Host Disease

Not yet recruiting
  • Graft-versus-Host Disease
  • ruxolitinib
  • (no location specified)
Jan 11, 2023

Acute-graft-versus-host Disease Trial in Minneapolis (Ruxolitinib 10 MG Oral Tablet, hCG, Corticosteroids)

Not yet recruiting
  • Acute-graft-versus-host Disease
  • Ruxolitinib 10 MG Oral Tablet
  • +2 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Chronic Hand Dermatitis Trial in Rochester (Ruxolitinib)

Recruiting
  • Chronic Hand Dermatitis
  • Ruxolitinib
  • Rochester, New York
    UR Medicine Dermatology College Town
Aug 9, 2022

Myelofibrosis Trial in United States (Selinexor, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Duarte, California
  • +4 more
Jan 30, 2023

Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Long-term Follow-up
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Atopic Dermatitis (AD) Trial (Ruxolitinib Cream)

Not yet recruiting
  • Atopic Dermatitis (AD)
  • Ruxolitinib Cream
  • (no location specified)
Jul 8, 2022

Assess Real-World Patient-Reported Outcomes With Fedratinib for

Recruiting
  • Myelofibrosis
    • City, State, Austria
      Local Institution
    Dec 16, 2022

    Hematopoietic Stem Cell Transplant (HSCT), Bronchiolitis Obliterans (BO) Trial in Cincinnati (Ruxolitinib)

    Recruiting
    • Hematopoietic Stem Cell Transplant (HSCT)
    • Bronchiolitis Obliterans (BO)
    • Ruxolitinib
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Aug 6, 2022

    Myelofibrosis Trial in Jinan (Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • Ruxolitinib
    • Jinan, Shandong, China
      Qilu Hospital of Shandong University
    Jul 3, 2022

    Bronchiolitis Obliterans Syndrome, Hematologic Malignancy Trial in Hangzhou (Ruxolitinib)

    Recruiting
    • Bronchiolitis Obliterans Syndrome
    • Hematologic Malignancy
    • Ruxolitinib
    • Hangzhou, Zhejiang, China
      The first Affiliated Hospital of Zhejiang University
    Oct 18, 2022

    Non-sclerotic Cutaneous Chronic Graft-versus-host Disease Trial in New York (topical ruxolitinib 1.5% cream, Topical

    Recruiting
    • Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
    • topical ruxolitinib 1.5% cream
    • Topical vehicle/moisturizer cream
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 20, 2022

    Myelofibrosis Trial in United States (Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • Ruxolitinib
    • Boston, Massachusetts
    • +4 more
    Oct 21, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Tucson, San Francisco (Ruxolitinib)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Ruxolitinib
    • Tucson, Arizona
    • +1 more
    Sep 22, 2022

    Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Singapore (Trametinib, Ruxolitinib)

    Recruiting
    • Colorectal Cancer
    • Pancreatic Adenocarcinoma
    • Singapore, Singapore
      National Cancer Centre
    Jun 10, 2022

    Lichen Sclerosus Trial in Canada, United States (Ruxolitinib cream, Vehicle cream)

    Recruiting
    • Lichen Sclerosus
    • Ruxolitinib cream
    • Vehicle cream
    • Birmingham, Alabama
    • +4 more
    Dec 13, 2022

    Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +13 more
    Jan 10, 2023

    QoL and Symptoms in Polycythemia Vera Receiving Ruxo inRoutine

    Not yet recruiting
    • Polycythemia Vera
    • Ruxolitinib
    • (no location specified)
    Sep 30, 2022

    Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Steroid Refractory Graft Versus Host Disease
    • Cellular Therapy
    • Ruxolitinib
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 9, 2022

    GVHD, JNS Kinase, Topical Administration Trial run by the NIAMS (Ruxolitinib 1.5% cream, vehicle cream)

    Terminated
    • Graft Versus Host Disease
    • +2 more
    • Ruxolitinib 1.5% cream
    • vehicle cream
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 21, 2022

    Atopic Dermatitis Trial in Montreal (ruxolitinib cream)

    Recruiting
    • Atopic Dermatitis
    • ruxolitinib cream
    • Montreal, Quebec, Canada
      Innovoderm Research
    Jul 12, 2022

    Discoid Lupus Erythematosus Trial in Rochester (Ruxolitinib)

    Enrolling by invitation
    • Discoid Lupus Erythematosus
    • Ruxolitinib
    • Rochester, New York
      UR Medicine Dermatology College Town
    May 20, 2022

    Multiple Myeloma Trial in Detroit, Charlotte (Carfilzomib, Ruxolitinib, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Detroit, Michigan
    • +1 more
    Jan 27, 2023

    Myelofibrosis Trial in Hangzhou (Jaktinib Hydrochloride Tablets)

    Recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablets
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital of Medical School of Zhejiang Univ
    Nov 28, 2022

    Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

    Recruiting
    • Myelofibrosis Due to and Following Polycythemia Vera
    • Basking Ridge, New Jersey
    • +6 more
    Jan 26, 2023

    Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

    Active, not recruiting
    • Chronic Myelomonocytic Leukemia
    • Leukemia
    • Ruxolitinib
    • Tampa, Florida
    • +4 more
    Nov 11, 2022